|
|
|
|
|
Detail |
| hsa-miR-29a |
|
Causal |
Overexpression of micro ribonucleic acid 29, highly up-regulated in diabetic rats, leads to insulin resistance in 3T3-L1 adipocytes. |
2007 |
|
|
|
|
|
|
| hsa-miR-29a |
|
Unspecified |
Distinctive patterns of microRNA expression in primary muscular disorders. |
2007 |
|
|
|
|
|
|
| hsa-miR-29a |
|
Unspecified |
Distinctive patterns of microRNA expression in primary muscular disorders. |
2007 |
|
|
|
|
|
|
| hsa-miR-29a |
|
Unspecified |
MicroRNA expression profiling in prostate cancer. |
2007 |
|
|
|
|
|
|
| hsa-miR-29a |
|
Unspecified |
MicroRNAs play an essential role in the development of cardiac hypertrophy. |
2008 |
|
|
|
|
|
|
| hsa-miR-29a |
|
Unspecified |
Cerebellar neurodegeneration in the absence of microRNAs. |
2007 |
|
|
|
|
|
|
| hsa-miR-29a |
|
Unspecified |
microRNA expression in the prefrontal cortex of individuals with schizophrenia and schizoaffective disorder. |
2007 |
|
|
|
|
|
|
| hsa-miR-29a |
|
Unspecified |
MicroRNAs are aberrantly expressed in hypertrophic heart: do they play a role in cardiac hypertrophy? |
2007 |
|
|
|
|
|
|
| hsa-miR-29a |
|
Unspecified |
A microRNA-based gene dysregulation pathway in Huntington's disease. |
2007 |
|
|
|
|
|
|
| hsa-miR-29a |
|
Causal |
MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B. |
2007 |
|
|
|
|
|
|
| hsa-miR-29a |
|
Causal |
Loss of microRNA cluster miR-29a/b-1 in sporadic Alzheimer's disease correlates with increased BACE1/beta-secretase expression. |
2008 |
|
|
|
|
|
|
| hsa-miR-29a |
|
Unspecified |
MicroRNA miR-29 modulates expression of immunoinhibitory molecule B7-H3: potential implications for immune based therapy of human solid tumors. |
2009 |
|
|
|
|
|
|
| hsa-miR-29a |
|
Unspecified |
Differential expression profiling of microRNAs and their potential involvement in renal cell carcinoma pathogenesis. |
2009 |
|
|
|
|
|
|
| hsa-miR-29a |
|
Causal |
MiRNA-29a regulates the expression of numerous proteins and reduces the invasiveness and proliferation of human carcinoma cell lines |
2009 |
|
|
|
|
|
|
| hsa-miR-29a |
|
Unspecified |
Characterization of global microRNA expression reveals oncogenic potential of miR-145 in metastatic colorectal cancer |
2009 |
|
|
|
|
|
|
| hsa-miR-29a |
|
Unspecified |
MicroRNA expression profiles in serous ovarian carcinoma. |
2008 |
|
|
|
|
|
|
| hsa-miR-29a |
|
Unspecified |
MicroRNA expression and identification of putative miRNA targets in ovarian cancer. |
2008 |
|
|
|
|
|
|
| hsa-miR-29a |
|
Unspecified |
The genomic analysis of erythrocyte microRNA expression in sickle cell diseases. |
2008 |
|
|
|
|
|
|
| hsa-miR-29a |
|
Unspecified |
MicroRNAs are differentially expressed in ulcerative colitis and alter expression of macrophage inflammatory peptide-2 alpha. |
2008 |
|
|
|
|
|
|
| hsa-miR-29a |
|
Unspecified |
The expression profile of microRNAs in a model of
7,12-dimethyl-benz[a]anthrance-induced oral carcinogenesis in Syrian hamster. |
2009 |
|
|
|
|
|
|